• 1. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

Introduction to (2-Bromo-4-chlorophenyl)boronic Acid (CAS No. 1451393-45-5)

(2-Bromo-4-chlorophenyl)boronic acid is a specialized organoboron compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science due to its versatile applications. This compound, identified by the chemical abstracts service number CAS No. 1451393-45-5, features a phenyl ring substituted with both bromine and chlorine atoms at the 2nd and 4th positions, respectively, and a boronic acid functional group. The unique structural characteristics of this molecule make it a valuable intermediate in organic synthesis, particularly in cross-coupling reactions such as the Suzuki-Miyaura coupling, which is widely employed in the construction of complex organic molecules.

The significance of (2-Bromo-4-chlorophenyl)boronic acid lies in its ability to participate in various chemical transformations that are pivotal for drug discovery and development. Boronic acids, in general, are known for their reactivity with transition metals, enabling the formation of new carbon-carbon bonds under mild conditions. This property has been exploited in the synthesis of biaryl compounds, which are prevalent in many pharmacologically active agents. The presence of both bromine and chlorine substituents on the phenyl ring enhances the reactivity of the boronic acid group, making it an ideal candidate for further functionalization.

In recent years, there has been a surge in research focused on developing novel boronic acid derivatives for therapeutic applications. For instance, studies have demonstrated the utility of (2-Bromo-4-chlorophenyl)boronic acid in the synthesis of targeted therapeutics that exhibit high selectivity and efficacy. One notable area of investigation has been its application in the development of kinase inhibitors, which are crucial for treating cancers and inflammatory diseases. The boronic acid moiety allows for precise modulation of molecular interactions, enabling the design of inhibitors that can selectively bind to specific enzymatic targets.

The structural motif of (2-Bromo-4-chlorophenyl)boronic acid also finds relevance in materials science, particularly in the fabrication of organic electronic devices. The bromine and chlorine substituents can influence the electronic properties of the phenyl ring, making it suitable for use as a building block in conductive polymers and organic semiconductors. Recent advancements in this field have shown that such boronic acid derivatives can be integrated into thin-film transistors (TFTs) and organic light-emitting diodes (OLEDs), offering improved performance and stability.

From a synthetic chemistry perspective, (2-Bromo-4-chlorophenyl)boronic acid serves as a versatile precursor for constructing more complex molecules. The boronic acid group can undergo various transformations, including oxidation to form esters or carboxylic acids, or reduction to yield alcohols. Additionally, the bromine and chlorine atoms can be displaced through nucleophilic aromatic substitution reactions, allowing for further diversification of the molecular structure. These attributes make it an indispensable tool in synthetic laboratories aiming to develop novel compounds with tailored properties.

The pharmaceutical industry has also leveraged the reactivity of (2-Bromo-4-chlorophenyl)boronic acid to develop innovative drug delivery systems. Boron-containing compounds have been explored as potential agents for targeted radionuclide therapy, where they act as carriers for radioactive isotopes that can selectively accumulate in tumor tissues. The stability and functionalizability of boronic acids have made them suitable candidates for this application, with ongoing research focusing on optimizing their efficacy and safety profiles.

In conclusion, (2-Bromo-4-chlorophenyl)boronic acid (CAS No. 1451393-45-5) is a multifaceted compound with broad applications across pharmaceutical chemistry and materials science. Its unique structural features enable participation in diverse chemical transformations, making it an invaluable intermediate for drug discovery, materials fabrication, and advanced synthetic methodologies. As research continues to uncover new applications for this compound, its importance is expected to grow further, driving innovation in both academic and industrial settings.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)